Skip to main content
. 2023 Aug 23;15(3):276–284. doi: 10.4274/jcrpe.galenos.2023.2023-1-13

Table 2. The clinical and laboratory findings of transwomen during the treatment of cross-sex hormone following GnRH analog or combined androgen receptor blockers.

graphic file with name JCRPE-15-276-g5.jpg